Karlijn Hummelink

A PD-1T signature as clinical applicable biomarker in NSCLC 153 4 Supplemental material Supplemental figures Figure S1. PD-1T quantification by an algorithm-based immunohistochemical (IHC) imaging approach. (A) IHC analysis of PD-1T TILs. Example of a PD-1T IHC high (≥90 per mm2) and (B) PD-1T IHC low (<90 per mm2) tumor with digital markup.

RkJQdWJsaXNoZXIy MTk4NDMw